Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 6—June 2011
Dispatch

Macrolide Resistance in Mycoplasma pneumoniae, Israel, 2010

Diana Averbuch, Carlos Hidalgo-Grass, Allon E. Moses, Dan Engelhard, and Ran Nir-PazComments to Author 
Author affiliations: Author affiliation: Hadassah–Hebrew University Medical Center, Jerusalem, Israel

Main Article

Table

Clinical information of patients positive for Mycoplasma pneumoniae, according to macrolide resistance genotype, Israel, 2010

Characteristic Macrolide-sensitive M. pneumoniae, n = 19* Macrolide-resistant M. pneumoniae, n = 9
Mean age, y, ± SD 7 ± 14.98 9 ± 8.39
>21
3
1
Admission, mean d, ± SD 4 ± 6.6 3 ± 8.2
Pneumonia confirmed by chest radiograph
16
9
Male/female 6/13 4/5
Ethnicity (Arab/Jewish)
5/14
1/8
Complications† 3 0
Concurrent conditions‡
4
2
Prior antibiotic use 9 6
Prior macrolide use 3 2

*Values are no. patients except as indicated. Clinical data were not available for 2 patients.
†Two patients had Stevens-Johnson syndrome, and Still’s disease developed in 1 patient.
‡Four patients had asthma, 1 had metabolic syndrome with cardiomyopathy, and 1 had carcinoma of the pancreas.

Main Article

1These authors contributed equally to this article.

Page created: August 03, 2011
Page updated: August 03, 2011
Page reviewed: August 03, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external